GNPX: Receives Patent Notice
Genprex receives notice of allowance from CIPO for patent covering use of Reqorsa gene therapy in combination with either PD-1 or PD-L1 antibodies for treatment of lung cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
GNPX Receives Patent Notice
Genprex receives a notice of allowance from the Canadian Intellectual Property Office for a patent claiming the combination of Reqorsa gene therapy with either PD-1 or PD-L1 antibodies to treat cancer